The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

• Main Authors: Daisuke Nishiya (Author), Soichiro Enomoto (Author), Takashi Omura (Author), Ryo Matsumoto (Author), Takanori Kusuyama (Author), Yasukatsu Izumi (Author), Hiroshi Iwao (Author), Kazuhide Takeuchi (Author), Minoru Yoshiyama (Author)
• Format: Book
• Published: Elsevier, 2007-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Long-acting Ca2+-channel blockers have been reported to be effective in treating ischemic heart disease. However, their effects on cardiac remodeling after myocardial infarction (MI) are still unclear. We performed this study to examine the effect of azelnidipine on left ventricular (LV) remodeling,...